Medidata Solutions Thought Leaders to Lead Sessions on CRO / EDC Partnerships and Clinical Technology Standards at November Global Events

* Reuters is not responsible for the content in this press release.

Thu Oct 29, 2009 3:00pm EDT

Thought Leaders to Present at Partnerships in 1st DIA China Annual Meeting,
Clinical Trials Congress and CDISC Interchange North America
NEW YORK--(Business Wire)--
Medidata Solutions (Nasdaq: MDSO), a leading global provider of hosted clinical
development solutions, today announced that members of its executive team will
deliver the following presentations at key industry events in November: 

1st DIA China Annual Meeting
November 2-3, 2009, Beijing, China

Presentation: "Computerized Systems in Clinical Research: Current Quality and
Data Integrity Concepts"
Speaker: Earl W. Hulihan, Senior Vice President, Regulatory Compliance
Session 2 - Track 3: Globalization
Date & Time: Tuesday, November 3, 12:30 p.m. CST 

8th Annual Partnerships in Clinical Trials Congress
November 4-5, 2009, Rotterdam, The Netherlands

Presentation: "Electronic Data Capture and Clinical Outsourcing: Partnering for
Success"
Speaker: Graham Bunn, VP, Global CRO Partnerships
STREAM: B
Date & Time: Thursday, November 5, 12:05 p.m. CET 

CDISC Interchange North America
November 11-12, 2009, Baltimore, MD

Presentation: "Using Incremental ODM Transactions in Systems Integration"
Speaker: Andrew Smith, Development Manager, R&D
Parallel Track 1. Session 6A: ODM
Date & Time: Thursday, November 12, 10:30-12:30 p.m. EST 

Presentation: "Standards-Based Approach to Creating One Elegant Multi-System
Solution"
Speakers: Carl Labb, Almac Clinical Technologies; Joseph Dustin, Medidata
Solutions; Scott Bradley, PHT
Parallel Track 1. Session 6A: ODM
Date & Time: Thursday, November 12, 10:30-12:30 p.m. EST 

About 1st DIA China Annual Meeting

DIA China Annual Meeting serves as an international and neutral forum to examine
important issues in global drug development and their relevance to China.
Speakers for major regulatory agencies, the industry, and academia will present
and lead the discussions. This multidisciplinary meeting will benefit all
professionals from regulatory agencies and institutions, the biopharmaceutical
industry, investigational sites, contract research organizations, and academia,
who must understand how drug development impacts China as the country takes an
increasingly pre-eminent place in the global arena. For more information, please
visit www.diahome.org. 

About Partnerships in Clinical Trials

This event focuses on strategic and practical case studies of the industry`s
most successful clinical partnerships. Attendees will have access to expert
analysis on the global economy, the implications for Pharma, comprehensive
updates of the changing service provider market and will have the opportunity to
network with industry leading professionals to solve all clinical outsourcing
challenges. For more information, please visit www.ct-partnerships.com. 

About CDSIC Interchange North America

CDISC is a global, open, multidisciplinary, non-profit organization that has
established standards to support the acquisition, exchange, submission and
archive of clinical research data and metadata. The CDISC Interchanges strive to
develop and support global, platform-independent data standards that enable
information system interoperability to improve medical research and related
areas of healthcare. CDISC standards are vendor-neutral, platform-independent
and freely available via the CDISC website. For more information, please visit
www.cdisc.org. 

About Medidata Solutions Worldwide

Medidata Solutions (www.mdsol.com) is a leading global provider of hosted
clinical development solutions that enhance the efficiency of customers`
clinical development processes and optimize their research and development
investments. Medidata products and services allow customers to achieve clinical
results more efficiently and effectively by streamlining the design, planning
and management of key aspects of the clinical development process, including
protocol development (Medidata Designer®), investigator benchmarking and
budgeting (Medidata Grants Manager), contract research organization (CRO)
benchmarking and budgeting (Medidata CRO Contractor), and the capture,
management, analysis and reporting of clinical trial data (Medidata Rave®).
Medidata`s diverse customer base spans pharmaceutical, biotechnology and medical
device companies, academic institutions, CROs and other research organizations,
and includes more than 20 of the top 25 global pharmaceutical companies.

Lois Paul & Partners
Susan McCarron, 781-782-5767
Susan_McCarron@lpp.com

Copyright Business Wire 2009

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.